113 related articles for article (PubMed ID: 16737146)
21. Promoting early detection tests for colorectal carcinoma and adenomatous polyps.
Berg A
Cancer; 2003 May; 97(9):2348. PubMed ID: 12712493
[No Abstract] [Full Text] [Related]
22. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
Jansen JB; van Rossum LG; Laheij RJ
Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
[TBL] [Abstract][Full Text] [Related]
23. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of adenomatous polyps and early colorectal cancer. Diagnostic and therapeutic implications].
Ghelase F; Mogoş DS; Mărgăritescu D; Iordache S; Ghelase MS; Râmboiu S; Mogoş G; Bică M; Săftoiu A; Georgescu I
Chirurgia (Bucur); 2009; 104(2):159-65. PubMed ID: 19499658
[TBL] [Abstract][Full Text] [Related]
25. [Experience with screening for colorectal carcinoma using the Haemoccult Test].
Zoubek V; Zoubková H
Cesk Zdrav; 1989 Mar; 37(3):117-21. PubMed ID: 2720834
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Colorectal Cancer and Adenomatous Polyps After a Two-Step Screening in Isfahan Province, Iran in 2018.
Soodejani MT; Mirzaei H; Manesh MM; Tabatabaei SM; Ghaderi A
J Gastrointest Cancer; 2020 Sep; 51(3):850-854. PubMed ID: 31656018
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
28. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
29. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
31. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
Nakama H; Zhang B; Kamijo N
Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
[TBL] [Abstract][Full Text] [Related]
33. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1).
Adler A; Roll S; Marowski B; Drossel R; Rehs HU; Willich SN; Riese J; Wiedenmann B; Rösch T;
Dis Colon Rectum; 2007 Oct; 50(10):1628-38. PubMed ID: 17694415
[TBL] [Abstract][Full Text] [Related]
34. The role of primary care in colorectal cancer screening: experience from Czech Republic.
Seifert B; Zavoral M; Fric P; Bencko V
Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
[TBL] [Abstract][Full Text] [Related]
35. [Colorectal cancer screening with colonoscopy].
Pereyra L; Gómez EJ; Mella JM; Cimmino DG; Boerr LA
Medicina (B Aires); 2013; 73(6):567-72. PubMed ID: 24356271
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
37. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer screening: do we practice what we preach?
Colquhoun P; Weiss EG; Efron J; Nogueras JJ; Vernava AM; Wexner SD
Surg Innov; 2006 Jun; 13(2):81-5. PubMed ID: 17012147
[TBL] [Abstract][Full Text] [Related]
39. [Population colorectal cancer screening in the Czech Republic].
Zavoral M; Vojtěchová G; Májek O; Ngo O; Grega T; Seifert B; Dušek L; Suchánek Š
Cas Lek Cesk; 2016; 155(1):7-12. PubMed ID: 26898786
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
